Merus (MRUS) Prices 5.5M Common Stock IPO at $10/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Merus B.V. (MRUS) IPO Opens Modestly Lower
May 19, 2016 10:28 AM EDTToday's IPO for Merus B.V. (Nasdaq: MRUS) opened for trading at $9.75 after pricing 5,500,000 common shares at an initial public offering price of $10.00 per share, below the expected $14-$16 range. The size of the offering was increased from 4,333,333.
Citigroup Global Markets Inc. and Jefferies LLC are acting as joint book-running managers for the offering, Guggenheim Securities, LLC is acting as lead manager for the offering and Wedbush PacGrow is acting as co-manager for the offering.
Merus B.V. is a clinical-stage immuno-oncology company... More



